Comparison 7. Methotrexate versus other DMARDs ‐ major outcomes > 6 months.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Serious adverse events	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
1.1 Ciclosporin A	1		Risk Ratio (M‐H, Random, 95% CI)	0.0 [0.0, 0.0]
2 Withdrawals due to adverse events	2		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
2.1 Ciclosporin A	1		Risk Ratio (M‐H, Random, 95% CI)	0.0 [0.0, 0.0]
2.2 Gold	1		Risk Ratio (M‐H, Random, 95% CI)	0.0 [0.0, 0.0]
2.3 Sulfasalazine	1		Risk Ratio (M‐H, Random, 95% CI)	0.0 [0.0, 0.0]